TXG
10x Genomics, Inc. · Healthcare · Market cap $9.8B
Insiders sold $12.2M net in the last 90 days ·6 sellers, 0 buyers· 7 of 12 sales under Rule 10b5-1 plans· latest Form 4 filed Sep 24, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$16.4M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Latest filing
Sep 24, 2026
Saxonov Serge
10x Genomics, Inc. (TXG) has 35 SEC Form 4 filings (60 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Sep 24, 2026.
Inside the rolling window, 6 insiders at 10x Genomics, Inc. reported no open-market purchases and 26 open-market sales totaling $16.4M. The most active filer is Chief Executive Officer Saxonov Serge with 11 filings. Insiders have net sold $14.9M over the trailing 6 months. The most recent open-market filing is a sale of 25,000 shares by Chief Executive Officer Saxonov Serge, dated Sep 22, 2026, worth $2.0M.
- Industry:Medical - Healthcare Information Services
- CEO:Serge Saxonov
- Employees:1,178
- HQ:Pleasanton, CA, US
- IPO:2019-09-12
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Executive Officer | Sale | 25,000 | $2.0M | Sep 24 | -10.1% | SEC ↗ | |
| Director | Sale | 5,723 | $465K | Sep 24 | -10.1% | SEC ↗ | |
| Chief Financial Officer | Sale | 46,388 | $3.0M | Sep 11 | — | SEC ↗ | |
| Director | Sale | 20,000 | $1.2M | Sep 8 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 10,486 | $668K | Aug 28 | — | SEC ↗ | |
| Director | Sale | 2,207 | $140K | Aug 26 | — | SEC ↗ | |
Taich AdamFirst in 3 months | Chief Financial Officer | Sale | 17,166 | $1.1M | Aug 26 | — | SEC ↗ |
Hindson Benjamin J.First in 3 months | See Remarks | Sale | 13,818 | $871K | Aug 26 | — | SEC ↗ |
| Chief Executive Officer | Sale | 18,545 | $1.2M | Aug 26 | — | SEC ↗ | |
Teichmann Sarah A.First filing | Director | Sale | 5,278 | $302K | Aug 17 | — | SEC ↗ |
Teichmann Sarah A.First filing | Director | Sale | 2,273 | $130K | Aug 17 | — | SEC ↗ |
STUELPNAGEL JOHN RFirst filing | Director | Sale | 20,000 | $1.2M | Aug 13 | — | SEC ↗ |
| Chief Executive Officer | Sale | 30,000 | $1.0M | Jun 24 | — | SEC ↗ | |
| Director | Sale | 5,723 | $187K | Jun 18 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 18,175 | $444K | May 27 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 10,718 | $265K | May 27 | — | SEC ↗ | |
Hindson Benjamin J.First in 3 months | See Remarks | Sale | 11,595 | $283K | May 27 | — | SEC ↗ |
Taich AdamFirst in 6 months | Chief Financial Officer | Sale | 15,098 | $369K | May 27 | — | SEC ↗ |
| Chief Executive Officer | Sale | 5,000 | $123K | Apr 16 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 10,000 | $191K | Mar 25 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 5,000 | $98K | Mar 25 | — | SEC ↗ | |
Saxonov SergeFirst in 3 months | Chief Executive Officer | Sale | 16,152 | $367K | Mar 4 | — | SEC ↗ |
Hindson Benjamin J.First in 3 months | See Remarks | Sale | 7,826 | $145K | Feb 25 | — | SEC ↗ |
Hindson Benjamin J.First filing | See Remarks | Sale | 8,283 | $157K | Nov 25 | — | SEC ↗ |
Saxonov SergeFirst filing | Chief Executive Officer | Sale | 13,261 | $252K | Nov 25 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does TXG have?
10x Genomics, Inc. (TXG) has 35 SEC Form 4 filings (60 transaction rows) in the rolling 365-day window, disclosed by 6 distinct insiders. Most recent filing: Sep 24, 2026.
When was the most recent SEC Form 4 filing for TXG?
The most recent Form 4 filing for TXG on Tracefour is dated Sep 24, 2026.
Who is the most active insider at TXG?
The most active SEC Form 4 filer at TXG in the rolling window is Chief Executive Officer Saxonov Serge, with 11 filings.
What is the net insider flow at TXG over the last 6 months?
Over the trailing 180 days, insiders at TXG have net sold $14.9M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at TXG in the current window?
Inside the rolling window, insiders at TXG bought $0 and sold $16.4M based on SEC Form 4 filings.
Can I get alerts for TXG insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at 10x Genomics, Inc. (TXG). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
10x Genomics, Inc. is in the Healthcare sector.